A naukri.com initiative
Bioengineer
1w
342
Image Credit: Bioengineer
Hope and Uncertainty in Metastatic Uveal Melanoma
- Metastatic cancer treatment has evolved with immunotherapy and targeted therapies, offering extended survival prospects but also introducing prognostic uncertainty.
- Metastatic uveal melanoma (mUM), a rare and aggressive eye cancer, faces uncertain outcomes despite therapeutic advancements.
- A qualitative study explored how individuals with mUM cope with treatment uncertainties, focusing on hope and realistic expectations.
- Participants used meta-cognitive strategies to balance hope and fear, highlighting the emotional challenges of living with mUM.
- Uncertainty in Illness Theory helped interpret patient experiences, revealing psychological and social impacts of uncertainty in mUM.
- The study emphasized the importance of tailored supportive care for managing uncertainty, anxiety, and communication challenges in mUM patients.
- Patients described 'scanxiety' related to routine disease surveillance scans, showcasing the emotional burden of living with metastatic cancer.
- Coping with uncertainty in cutting-edge treatments involves 'hoping for the best while preparing for the worst,' requiring nuanced clinical support.
- Supportive care strategies should evolve to address the psychological sequelae of prognostic ambiguity in metastatic melanoma treatment.
- This study highlights the need for integrated psychological interventions to complement medical advancements in rare cancers like mUM.
Read Full Article
20 Likes
For uninterrupted reading, download the app